Background and Purpose-Hyperglycemia after stroke is associated with larger infarct volume and poorer functional outcome. In an animal stroke model, the association between serum glucose and infarct volume is described by a U-shaped curve with a nadir Ϸ7 mmol/L. However, a similar curve in human studies was never reported. The objective of the present study is to investigate the association between serum glucose levels and functional outcome in patients with acute ischemic stroke. Methods-We analyzed 1446 consecutive patients with acute ischemic stroke. Serum glucose was measured on admission at the emergency department together with multiple other metabolic, clinical, and radiological parameters. Key Words: acute ischemic stroke Ⅲ functional outcome Ⅲ J-shaped association Ⅲ poststroke hyperglycemia Ⅲ serum glucose H yperglycemia is commonly encountered in patients with acute ischemic stroke, with estimates varying and depending on the frequency of glucose measurements and the criteria used to define hyperglycemia. 1 The incidence of poststroke hyperglycemia is estimated at 45% in studies with frequent glucose measurements and a threshold value of 7 mmol/L to define hyperglycemia. 2 Because the prevalence of previously diagnosed diabetes mellitus in stroke patients is estimated between 10% and 20%, diabetes mellitus is obviously not the only underlying pathophysiologic mechanism of poststroke hyperglycemia. 3 Previously undiagnosed diabetes mellitus and impaired glucose tolerance account for a further 5% to 28%. 3 In addition, 10% to 20% of stroke patients present with hyperglycemia with normal glycosylated hemoglobin. 4 This is considered as a neurohumoral stress response, although studies on the association between serum cortisol and poststroke hyperglycemia yielded conflicting results. 4 Hyperglycemia after stroke is independently associated with infarct volume in magnetic resonance and spectroscopy studies, 5 and poor functional outcome. 6 However, the UK Glucose Insulin in Stroke Trial (GIST-UK) showed no clinical benefit of treating hyperglycemia rapidly with glucose-potassium-insulin infusion. 7 Moreover, mortality was higher in those patients with greatest glucose reductions (Ͼ2 mmol/L), implying a possibly deleterious effect when glucose levels decrease to less than a critical threshold. 7 An animal model study demonstrated that the association between serum glucose and cerebral infarct volume is described by a U-shaped curve with a nadir of approximately 7 mmol/L. 8 However, a similar curve in human studies was never reported.Continuing medical education (CME) credit is available for this article. Go to http://cme.ahajournals.org to take the quiz.